Tag: prostate cancer

A new mRNA-based vaccine shows promise in helping the immune system recognize and attack prostate cancer tumors, overcoming the resistance seen in cold tumors. Researchers report encouraging lab results and hope this breakthrough may improve future cancer treatments. keep reading

Recent research uncovers substantial agreement between MRI-targeted prostate biopsy results and surgical specimens, offering fresh insight into biopsy accuracy for prostate cancer. Rates of concordance are highest for more aggressive disease, yet lower for lower-grade findings. keep reading

Prostate cancer is the most common nonskin cancer in men, yet many don’t know the key facts that shape detection and treatment. From risks to survival rates, here are 10 essential insights every patient should understand. keep reading

Recent studies are questioning whether prostatectomies can sometimes proceed without a prior biopsy, thanks to high-precision imaging techniques like mpMRI and PSMA PET scans. While this approach offers some benefits, including fewer procedural risks, it sparks important debates about accuracy, patient safety, and treatment planning. keep reading

Emerging research reveals that early PSA after radiation and androgen deprivation therapy can help predict prostate cancer outcomes. Meanwhile, a new genomic test is showing potential for identifying which patients face higher risk of long-term urinary side effects. keep reading

Losing excess weight and adopting healthier habits may help men lower their prostate cancer risk. Recent studies suggest web-based and home programs offer promising tools for lasting lifestyle changes and improved health outcomes. keep reading

“I wish I hadn’t chosen that treatment.” For many men with localized prostate cancer, decision regret is a painful reality. Studies show that clear communication, decision aids, and shared decision-making can help patients feel more confident and supported in their choices. keep reading

For decades, standard TRUS biopsies relied on 12+ random needles—missing aggressive cancers up to 46% of the time and increasing risks of infection. Today, real-time MRI-guided biopsies use just 2–4 precisely targeted needles, giving doctors clearer answers with fewer side effects. Discover why MRI-guided precision is changing prostate cancer diagnosis. keep reading

A recent study confirms that the new PI-FAB scoring system is highly reliable for evaluating MRI scans after focal therapy. With strong agreement among radiologists, PI-FAB offers patients and clinicians more confidence in long-term monitoring and peace of mind. keep reading

A groundbreaking study reveals how artificial intelligence outperforms traditional methods in prostate cancer risk stratification. By leveraging deep learning and digital biopsy data, AI enhances accuracy, reduces errors, and improves treatment planning for better outcomes. Learn how this innovative technology is transforming prostate cancer diagnosis and care. keep reading